5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.66▲ | 7.58▲ | 7.50▲ | 7.27▲ | 6.51▲ |
MA10 | 7.62▲ | 7.49▲ | 7.45▲ | 7.24▲ | 6.74▲ |
MA20 | 7.57▲ | 7.44▲ | 7.17▲ | 6.42▲ | 7.18▲ |
MA50 | 7.46▲ | 7.12▲ | 7.20▲ | 6.68▲ | 10.70▼ |
MA100 | 7.44▲ | 7.20▲ | 6.71▲ | 7.17▲ | 11.21▼ |
MA200 | 7.16▲ | 6.60▲ | 6.29▲ | 9.71▼ | 17.98▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | 0.018▲ | 0.053▲ | 0.159▲ | 0.234▲ |
RSI | 65.387▲ | 71.954▲ | 69.433▲ | 63.564▲ | 47.707▼ |
STOCH | 90.368▲ | 82.958▲ | 81.669▲ | 82.889▲ | 47.027 |
WILL %R | -20.000▲ | -7.500▲ | -3.191▲ | -1.345▲ | -8.917▲ |
CCI | 96.682 | 158.266▲ | 113.325▲ | 93.298 | 48.671 |
Tuesday, April 29, 2025 01:00 PM
WATERTOWN, Mass. and GOSSELIES, Belgium, March 25, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and ...
|
Monday, April 28, 2025 02:36 PM
Investing.com -- iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported a narrower-than-expected loss for the first quarter of 2025, sending its shares up 2% in response to the earnings beat.
|
Monday, April 28, 2025 01:30 PM
Topline interim dataset from GALAXIES Lung-201 with >240 patients anticipated in 2Q25 - Interim datasets from GALAXIES H&N-202 and TIG-006 HNSCC with ~200 patients anticipated in 2025 - Cash balance ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 7.575 | 7.69 | 7.41 | 7.66 | 81,767 |
01/05/25 | 7.27 | 7.56 | 7.265 | 7.50 | 1,154,456 |
30/04/25 | 6.79 | 7.30 | 6.61 | 7.25 | 816,734 |
29/04/25 | 7.30 | 7.30 | 6.585 | 6.86 | 386,148 |
28/04/25 | 7.31 | 7.365 | 7.02 | 7.07 | 419,801 |
25/04/25 | 7.35 | 7.50 | 7.225 | 7.35 | 343,870 |
24/04/25 | 7.03 | 7.46 | 7.01 | 7.46 | 264,314 |
23/04/25 | 7.52 | 7.56 | 7.05 | 7.15 | 716,806 |
22/04/25 | 6.71 | 7.50 | 6.71 | 7.45 | 1,277,610 |
21/04/25 | 6.44 | 6.72 | 6.27 | 6.62 | 479,128 |
|
|
||||
|
|
||||
|
|